Although upregulation of mucosal defense chemokines that represent disruption of intestinal immunity is well known in HIV infection, other inflammatory pathways, such as CCR5 ligands, CXCR3 ligands, and growth factors proteins, were less known and can pave the way toward new therapeutic options. The gene discussed is CXCR3; the disease is HIV infectious disease.